UK Clinical AI company Sensyne Health Plc (LON: SNS) has entered a five-year non-exclusive Strategic Research Agreement (SRA) with Hampshire Hospitals NHS Foundation Trust.
- The agreement will enable the fair application of clinical AI research to enhance patient care and quicken research into new medicines.
- The Hampshire Hospitals dataset covers 500,000 unique patient records, with 200,000 annual hospital admissions and brings a combined dataset of 6.1 million patients for analysis by Sensyne.
- As per the agreement, the Hampshire Trust will get 1,428,571 ordinary shares equivalent to around 1.11 per cent of the existing issued share capital of the company.
- On 25 November 2020, the stocks of the company traded higher by 3.60% from its previous closing, hovering at around GBX 144.00 at 10:38 AM GMT+1.